Freshpet (NASDAQ:FRPT) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 71.43 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $165.80 million which beat the analyst consensus estimate of $152.11 million by 9.00 percent. This is a 43.09 percent increase over sales of $115.87 million the same period last year.
ARS Pharmaceuticals Announces Scheduling Of A Type A Meeting With The U.S. FDA By The End Of October For neffy (Epinephrine Nasal Spray)
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better protect patients from severe allergic reactions that could lead to anaphylaxis, today
